Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study

dc.contributor.authorInal, A.
dc.contributor.authorIsikdogan, A.
dc.contributor.authorKos, T.
dc.contributor.authorAlgin, E.
dc.contributor.authorGumus, M.
dc.contributor.authorDikilitas, M.
dc.contributor.authorUncu, D.
dc.date.accessioned2026-08-12T18:12:25Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1200/jco.2011.29.15_suppl.e14534
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15
dc.identifier.orcid0000-0002-7991-0036
dc.identifier.urihttps://doi.org/10.1200/jco.2011.29.15_suppl.e14534
dc.identifier.urihttps://hdl.handle.net/11508/63860
dc.identifier.volume29
dc.identifier.wosWOS:000208880303588
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAmer Soc Clinical Oncology
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleGemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
dc.typeConference Object

Dosyalar